(Eagle News) — Drug manufacturer Sanofi Pasteur on Monday reiterated it would not refund the Philippine government the P3 billion it used to purchase the anti-dengue vaccine Dengvaxia. Sanofi also said it would not set up an indemnification fund as requested by the Department of Health.  “We stand firmly behind our product. Refunding the used doses of Dengvaxia would imply that the vaccine is ineffective, which is not the case. And at this time, there is […]